[Treatment of chronic diseases of connective tissue by cytostatic drugs].
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D002699:Chlorambucil / Q000009:adverse effects / Q000627:therapeutic use*; D003095:Collagen Diseases / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D013852:Thiotepa / Q000009:adverse effects / Q000627:therapeutic use*; D014228:Triaziquone / Q000009:adverse effects / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D013852:Thiotepa; D015122:Mercaptopurine; D014228:Triaziquone; D001379:Azathioprine; D008727:Methotrexate
Tratamiento de las enfermedades crónicas del tejido conjuntivo por los citostáticos.